Dopamine D2 receptor occupancy and clinical effects: A systematic review and pooled analysis

Hiroyuki Uchida, Hiroyoshi Takeuchi, Ariel Graff-Guerrero, Takefumi Suzuki, Koichiro Watanabe, David C. Mamo

Research output: Contribution to journalArticle

84 Citations (Scopus)

Abstract

Positron emission tomography (PET) studies proposed a therapeutic window of D2 receptor occupancy (65%-80%) of antipsychotics for the treatment of schizophrenia in young adults. However, this conclusion has been drawn from clinical PET studies using small sample sizes (<20). Prospective PET studies that measured D2 occupancy levels and assessed extrapyramidal side effects (EPS) and/or treatment response induced by antipsychotics (excluding partial agonists) were identified, using MEDLINE and EMBASE (last search: March 2010). Individual subjects were divided into 2 groups based on EPS status (ie, presence or lack of newly emergent EPS) and treatment response (ie, a ≥ 25% or ≥ 50% reduction in the Positive and Negative Syndrome Scale or Brief Psychiatric Rating Scale). To evaluate the performance of this binary classification, sensitivity, specificity, and accuracy of consecutive cutoff points in the D2 occupancy were calculated: Accuracy = (True Positive + True Negative)/Total N. Twelve studies, including a total of 82 subjects, were included in our analyses. The cutoff points associated with 0.5 or greater in both sensitivity and specificity with the greatest accuracy were 77% to 78% for EPS, 60% for a 25% or greater symptom reduction, and 72% for a 50% or greater symptom reduction. These findings support the presence of a therapeutic window of 60% to 78% D2 occupancy of antipsychotics in young adults with schizophrenia and may suggest the presence of a continuum of effectiveness with increasing occupancy within this therapeutic window.

Original languageEnglish
Pages (from-to)497-502
Number of pages6
JournalJournal of Clinical Psychopharmacology
Volume31
Issue number4
DOIs
Publication statusPublished - 2011 Aug

Fingerprint

Dopamine D2 Receptors
Positron-Emission Tomography
Antipsychotic Agents
Young Adult
Schizophrenia
Therapeutics
Brief Psychiatric Rating Scale
Sensitivity and Specificity
MEDLINE
Sample Size

Keywords

  • antipsychotic
  • dopamine
  • dopamine D receptor
  • positron emission tomography
  • schizophrenia

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Pharmacology (medical)

Cite this

Dopamine D2 receptor occupancy and clinical effects : A systematic review and pooled analysis. / Uchida, Hiroyuki; Takeuchi, Hiroyoshi; Graff-Guerrero, Ariel; Suzuki, Takefumi; Watanabe, Koichiro; Mamo, David C.

In: Journal of Clinical Psychopharmacology, Vol. 31, No. 4, 08.2011, p. 497-502.

Research output: Contribution to journalArticle

Uchida, Hiroyuki ; Takeuchi, Hiroyoshi ; Graff-Guerrero, Ariel ; Suzuki, Takefumi ; Watanabe, Koichiro ; Mamo, David C. / Dopamine D2 receptor occupancy and clinical effects : A systematic review and pooled analysis. In: Journal of Clinical Psychopharmacology. 2011 ; Vol. 31, No. 4. pp. 497-502.
@article{2aa567c5c2d9468ab16964adcbd2e155,
title = "Dopamine D2 receptor occupancy and clinical effects: A systematic review and pooled analysis",
abstract = "Positron emission tomography (PET) studies proposed a therapeutic window of D2 receptor occupancy (65{\%}-80{\%}) of antipsychotics for the treatment of schizophrenia in young adults. However, this conclusion has been drawn from clinical PET studies using small sample sizes (<20). Prospective PET studies that measured D2 occupancy levels and assessed extrapyramidal side effects (EPS) and/or treatment response induced by antipsychotics (excluding partial agonists) were identified, using MEDLINE and EMBASE (last search: March 2010). Individual subjects were divided into 2 groups based on EPS status (ie, presence or lack of newly emergent EPS) and treatment response (ie, a {\^a}‰¥ 25{\%} or {\^a}‰¥ 50{\%} reduction in the Positive and Negative Syndrome Scale or Brief Psychiatric Rating Scale). To evaluate the performance of this binary classification, sensitivity, specificity, and accuracy of consecutive cutoff points in the D2 occupancy were calculated: Accuracy = (True Positive + True Negative)/Total N. Twelve studies, including a total of 82 subjects, were included in our analyses. The cutoff points associated with 0.5 or greater in both sensitivity and specificity with the greatest accuracy were 77{\%} to 78{\%} for EPS, 60{\%} for a 25{\%} or greater symptom reduction, and 72{\%} for a 50{\%} or greater symptom reduction. These findings support the presence of a therapeutic window of 60{\%} to 78{\%} D2 occupancy of antipsychotics in young adults with schizophrenia and may suggest the presence of a continuum of effectiveness with increasing occupancy within this therapeutic window.",
keywords = "antipsychotic, dopamine, dopamine D receptor, positron emission tomography, schizophrenia",
author = "Hiroyuki Uchida and Hiroyoshi Takeuchi and Ariel Graff-Guerrero and Takefumi Suzuki and Koichiro Watanabe and Mamo, {David C.}",
year = "2011",
month = "8",
doi = "10.1097/JCP.0b013e3182214aad",
language = "English",
volume = "31",
pages = "497--502",
journal = "Journal of Clinical Psychopharmacology",
issn = "0271-0749",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

TY - JOUR

T1 - Dopamine D2 receptor occupancy and clinical effects

T2 - A systematic review and pooled analysis

AU - Uchida, Hiroyuki

AU - Takeuchi, Hiroyoshi

AU - Graff-Guerrero, Ariel

AU - Suzuki, Takefumi

AU - Watanabe, Koichiro

AU - Mamo, David C.

PY - 2011/8

Y1 - 2011/8

N2 - Positron emission tomography (PET) studies proposed a therapeutic window of D2 receptor occupancy (65%-80%) of antipsychotics for the treatment of schizophrenia in young adults. However, this conclusion has been drawn from clinical PET studies using small sample sizes (<20). Prospective PET studies that measured D2 occupancy levels and assessed extrapyramidal side effects (EPS) and/or treatment response induced by antipsychotics (excluding partial agonists) were identified, using MEDLINE and EMBASE (last search: March 2010). Individual subjects were divided into 2 groups based on EPS status (ie, presence or lack of newly emergent EPS) and treatment response (ie, a ≥ 25% or ≥ 50% reduction in the Positive and Negative Syndrome Scale or Brief Psychiatric Rating Scale). To evaluate the performance of this binary classification, sensitivity, specificity, and accuracy of consecutive cutoff points in the D2 occupancy were calculated: Accuracy = (True Positive + True Negative)/Total N. Twelve studies, including a total of 82 subjects, were included in our analyses. The cutoff points associated with 0.5 or greater in both sensitivity and specificity with the greatest accuracy were 77% to 78% for EPS, 60% for a 25% or greater symptom reduction, and 72% for a 50% or greater symptom reduction. These findings support the presence of a therapeutic window of 60% to 78% D2 occupancy of antipsychotics in young adults with schizophrenia and may suggest the presence of a continuum of effectiveness with increasing occupancy within this therapeutic window.

AB - Positron emission tomography (PET) studies proposed a therapeutic window of D2 receptor occupancy (65%-80%) of antipsychotics for the treatment of schizophrenia in young adults. However, this conclusion has been drawn from clinical PET studies using small sample sizes (<20). Prospective PET studies that measured D2 occupancy levels and assessed extrapyramidal side effects (EPS) and/or treatment response induced by antipsychotics (excluding partial agonists) were identified, using MEDLINE and EMBASE (last search: March 2010). Individual subjects were divided into 2 groups based on EPS status (ie, presence or lack of newly emergent EPS) and treatment response (ie, a ≥ 25% or ≥ 50% reduction in the Positive and Negative Syndrome Scale or Brief Psychiatric Rating Scale). To evaluate the performance of this binary classification, sensitivity, specificity, and accuracy of consecutive cutoff points in the D2 occupancy were calculated: Accuracy = (True Positive + True Negative)/Total N. Twelve studies, including a total of 82 subjects, were included in our analyses. The cutoff points associated with 0.5 or greater in both sensitivity and specificity with the greatest accuracy were 77% to 78% for EPS, 60% for a 25% or greater symptom reduction, and 72% for a 50% or greater symptom reduction. These findings support the presence of a therapeutic window of 60% to 78% D2 occupancy of antipsychotics in young adults with schizophrenia and may suggest the presence of a continuum of effectiveness with increasing occupancy within this therapeutic window.

KW - antipsychotic

KW - dopamine

KW - dopamine D receptor

KW - positron emission tomography

KW - schizophrenia

UR - http://www.scopus.com/inward/record.url?scp=79960616055&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79960616055&partnerID=8YFLogxK

U2 - 10.1097/JCP.0b013e3182214aad

DO - 10.1097/JCP.0b013e3182214aad

M3 - Article

C2 - 21694629

AN - SCOPUS:79960616055

VL - 31

SP - 497

EP - 502

JO - Journal of Clinical Psychopharmacology

JF - Journal of Clinical Psychopharmacology

SN - 0271-0749

IS - 4

ER -